Yabang PeptideTirzepatide
Ordered Tirzepatide from Yabang Peptide? Mail in a sample (US only) and let us test it for free.
Test my supplyYabang Peptide's tirzepatide rating is held down by volatile purity evidence, including repeated sub-99.5% misses and a May 2026 result at 79.4% purity with +28% fill. Later results improved, but the pattern is mixed.
Corporate/B2B records and the domain-certificate trail tell a shorter story than Yabang’s advertised history. The report maps the trading-company identity, template-site residue, nonfunctional social links, and buyer reports around WhatsApp sales, payment holds, and slow shipping.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Yabang Peptide rows.
Cancel anytime
About Yabang Peptide test results from Finnrick
Yabang Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 35 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Yabang Peptide peptides in this dataset are BPC-157 (4 tests), GHK-Cu (3 tests) and Retatrutide (16 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 35 recent tests.
Ordered Tirzepatide from Yabang Peptide? Mail in a sample (US only) and let us test it for free.
Test my supply